Author

Yuan Li

Stanford MedicineORCID 0000-0002-3171-8053Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Yuan Li13 papers · Lund University

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Alexandre de Fraipont· 1 shared Andrew Richardson· 1 shared Antonios ChronopoulosiD· 1 shared Gregory W. CharvilleiD· 1 shared Koshi Kunimoto· 1 shared Lóránd VánczaiD· 1 shared Nadine NagyiD· 1 shared Natalie Julia TorokiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPathology

Alexandre de Fraipont

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Hyaluronan and CD44 targeting reverses early matrix changes, proinflammatory signals and fibrosis in primary sclerosing cholangitis

Vidushi Bansal, Lóránd Váncza, Weiguo Fan, Koshi Kunimoto, Tzu Han Lo, Nhu Nguyen, Andrew Richardson, Antonios Chronopoulos, Rui Chen, Xingcai Zhang, Alexandre de Fraipont, Yuan Li, Yi Wei, Gregory W. Charville, Shuang Li, , Natalie Julia Torok

This study identifies HA and CD44 as mediators of matrix changes and fibrosis in PSC, showing their targeting can reverse disease progression.

bioRxiv · Jul 24, 2026 · PreprintPathology